Programming to reduce ICD shocks

Links shared publicly online about this topic.

  • 1,171
    total visits

Programming to reduce ICD shocks

theheart.org

By programming certain variables, including faster VT/VF thresholds and longer detection durations, among others, overall shock reduction was reduced between 17% and 28%, according to investigators.

View full resource at theheart.org

Tags: Advanced Life Support

  • Share

Most Recently Shared on May 13, 2010 at 9:33 pm By:

theheartorg Shelley Wood

More strategic defibrillator programming can reduce shocks: By programming certain variables, including faster VT/... http://bit.ly/blhG95

2 years ago...

Symposier - CRISP-AMI: IABP Does Not Reduce Infarct Size

symposier.com — “Uploaded and shared in Youtube by: ACCinTouch — CRISP-AMI: A multi-center, randomized controlled trial, which included 337 patient with acute anterior STEMI but without cardiogenic shock. Peter C. Block, MD, FACC Statements or opinions expressed in this program reflects the views of the contributors and do not reflect the official policy of the ACCF, unless otherwise noted.View full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on September 30, 2011 at 11:45 pm By:

SympoCardiology Symposier Cardiology Cardiology and Health Business

CRISP-AMI: 337 patient with acute anterior STEMI but without cardiogenic shock. http://t.co/cUprYmb2

7 months ago...

Medical News: Study Hints at Efficacy of Angina Drug in ICD Patients - in Cardiovascular, Arrhythmias from MedPage Today

medpagetoday.com — “Ranolazine (Ranexa), an antianginal, reduced episodes of ventricular tachycardia and shocks from implantable cardioverter defibrillators (ICDs) in patients refractory to antiarrhythmic drugs, a smallView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 8, 2011 at 8:41 pm By:

MedicalNews Medical News Health News

Study Hints at Efficacy of Angina Drug in ICD Patients (CME/CE) http://t.co/tfe329u

7 months ago...

BIOTRONIK Home Monitoring reduces inappropriate shocks, improves ICD battery longevity

news-medical.net — “BIOTRONIK, a leading manufacturer of implantable cardiac devices and the pioneer of wireless remote monitoring technology, announced today the first presentation of results from the ECOST randomized controlled trial.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 30, 2011 at 11:16 am By:

NewsMedical News-Medical.Net Health News

BIOTRONIK Home Monitoring reduces inappropriate shocks, improves ICD battery longevity: BIOTRONIK, a leading man... http://t.co/xnPHIJc

8 months ago...

ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase From Device Shock

medicalnewstoday.com — “Boston Scientific Corporation (NYSE: BSX) announced results from an analysis of its ALTITUDE® Clinical Science program, which demonstrated that defibrillator therapy saves lives from lethal arView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 6, 2011 at 8:33 am By:

Drugs_Devices Drugs and Devices OW OW Health

ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase From Device Shock: Bos... http://bit.ly/ilDpOI #MedDevice

11 months ago...

Medtronic Announces FDA Approval Of Protecta™ Implantable Defibrillators That Reduce Inappropriate Shocks

medicalnewstoday.com — “Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Protecta™ portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchroView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 29, 2011 at 11:30 am By:

Drugs_Devices Drugs and Devices OW OW Health

Medtronic Announces FDA Approval Of Protectaâ„¢ Implantable Defibrillators That Reduce Inappropriate Sh... http://bit.ly/eXqsRP #MedDevice

1 year ago...

Medtronic Announces FDA Approval Of Protecta™ Implantable Defibrillators That Reduce Inappropriate Shocks

medicalnewstoday.com — “Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Protecta™ portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchroView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 29, 2011 at 11:12 am By:

HeartsHealth Heart Health Health News

MedicalNewsToday: Medtronic Announces FDA Approval Of Protectaâ„¢ Implantable: http://bit.ly/eHylJl Full http://bit.ly/hTbMiF

1 year ago...

Late Breaking Clinical Trial Validates Value Of Shock Reduction Strategies

medicalnewstoday.com — “Medtronic, Inc. (NYSE: MDT) released new evidence demonstrating that key shock-reduction programming strategies significantly reduced implantable cardioverter-defibrillator (ICD) and cardiac resynView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 14, 2010 at 1:43 pm By:

HeartsHealth Heart Health Health News

MedicalNewsToday: Late Breaking Clinical Trial Validates Value Of Shock Reduction Strategies http://bit.ly/ap5gzO Full http://bit.ly/c9T96p

2 years ago...

A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary preventi

eurheartj.oxfordjournals.org — “A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study " Eur Heart JView full resource at eurheartj.oxfordjournals.org

  • View Related
  • Share

Most Recently Shared on November 25, 2009 at 10:50 am By:

escardio European Cardiology Cardiology and Medical Society

RELEVANT study on a simplified, biventricular defibrillator... http://tinyurl.com/ylbss3x

2 years ago...

Implantable device reduces hospitalizations for heart failure | Booster Shots | Los Angeles Times

latimesblogs.latimes.com — “An implantable device that shocks an erratically beating heart back into normality and works to keep both ventricles of the heart beating in synchrony has reduced hospitalizations for heart failure by 41%, according to results reported today at the European...View full resource at latimesblogs.latimes.com

  • View Related
  • Share

Most Recently Shared on September 1, 2009 at 6:40 pm By:

LATimeshealth LA Times Health News Health News

Implantable device reduces hospitalizations for heart failure http://bit.ly/weVPE

3 years ago...

Advertisement